brigatinib

CHEBI:CHEBI_752062

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1988786
generic_name
brigatinib
dosage_form
POWDER
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
route
ORAL
active_ingredient_strength
10 kg/10kg
pharm_class_moa
Tyrosine Kinase Inhibitors [MoA]
pharm_class
Tyrosine Kinase Inhibitors [MoA]
nui
N0000190118
pharm_class_epc
Kinase Inhibitor [EPC]
marketing_start_date
20170428
labeler_name
Curia New York, Inc.
manufacturer_name
Takeda Pharmaceuticals America, Inc.
package_marketing_start_date
20171002
brand_name
Alunbrig
brand_name_base
Alunbrig
product_ndc
63020-090
application_number
NDA208772
spl_id
ec1d52e0-6032-775f-e053-2995a90a0835
active_ingredient_name
BRIGATINIB
package_ndc
63020-090-30
package_description
30 TABLET, FILM COATED in 1 BOTTLE (63020-090-30)
unii
HYW8DB273J
spl_set_id
0fe9ff20-d402-41f3-bc1e-7002ea7007db
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class